Results 221 to 230 of about 195,293 (269)

LDL Apheresis: A Novel Technique (LIPOCOLLECT 200)

Artificial Organs, 2009
AbstractTherapeutic means to lower Lp(a) are limited. The most effective method to reduce plasma Lp(a) concentration significantly is therapeutic apheresis, namely, low‐density lipoprotein (LDL) lipoprotein(a) (Lp(a)) apheresis. A novel technique based on reusable LDL adsorber called Lipocollect 200 (Medicollect, Rimbach, Germany) allows the removal of
STEFANUTTI, Claudia, DI GIACOMO S, MAZZARELLA, Bruno, CASTELLI A.   +3 more
openaire   +3 more sources

Applications of LDL-apheresis in nephrology

Clinical and Experimental Nephrology, 2008
LDL-apheresis (LA) was originally used for familial hyperlipidemia, and then in Japan extended to use for the treatment of patients with peripheral arterial disease (PAD) and nephrotic syndrome due to steroid-resistant focal glomerular sclerosis (FGS). The reason why this treatment is applicable for these disorders is due to the fact that LA exerts its
openaire   +2 more sources

[Plaque stabilization by LDL apheresis?].

Herz, 1999
Vulnerable lipid-rich plaques are often the cause of atherothrombotic events leading to unstable angina and/or to acute myocardial infarction. Consequent long-term LDL-lowering by drugs as shown by the most important intervention studies lead to plaque stabilization as shown by the significant reduction of myocardial reinfarction.
P, Schuff-Werner, V, Schettler
openaire   +2 more sources

Liposorber® LA-15 system for LDL apheresis in resistant nephrotic syndrome patients

Pediatric nephrology (Berlin, West), 2021
Mohammad F Al-Mousily, O. Nicoara, D. Selewski, K. Twombley   +3 more
semanticscholar   +1 more source

Low-density lipoprotein (LDL) oxidizability before and after LDL apheresis

Metabolism, 1999
Oxidation of low-density lipoprotein (LDL) plays a major role in the development of atherosclerosis. Hypercholesterolemia has been associated with enhanced in vitro oxidation of LDL, and lipid-lowering therapy reduces LDL oxidizability. In the present study, we investigated whether LDL apheresis performed with different techniques affects in vitro ...
M G, Donner, K G, Parhofer, W O, Richter, P, Schwandt   +3 more
openaire   +2 more sources

[LDL-apheresis: current status].

La Clinica terapeutica, 2001
State of the art of LDL-apheresis and treatment of severe familiar hypercholesterolemia.Clinical experience of treatment with LDL-apheresis of pediatric and adult patients with familial hypercholesterolemia using the following techniques: D.A.L.I., H.E.L.P., D.S.C.The outcome of treatment with LDL-apheresis in young patients, using the most recently ...
C, Stefanutti, A, Vivenzio, G, Lucani, S, Di Giacomo   +3 more
openaire   +1 more source

Development of Selective Low‐Density Lipoprotein (LDL) Apheresis System: Immobilized Polyanion as LDL‐Specific Adsorption for LDL Apheresis System

Therapeutic Apheresis, 1996
Abstract: Guest Editor's Introduction: The binding site of the human LDL receptor is rich in anionic amino acids, and interacts with apolipoprotein‐B by the electrostatic force. Therefore, anionic ligands could be used for the selective adsorption of LDL without HDL adsorption. Based upon this concept, Kaneka Co. developed LDL adsorbent. The adsorbent
openaire   +2 more sources

[LDL apheresis: an update and overview. LDL apheresis in Sardinia, Italy (SMILDLa)].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2012
LDL apheresis (LDLa) is an invasive therapeutic tool to control qualitative and quantitative disorders of lipid metabolism. It is aimed at achieving a metabolic balance in association with lipid-lowering drugs in patients with severe, genetically determined or acquired dyslipidemia who do not reach clinically adequate LDL-cholesterol (LDL-C) levels (
Claudia, Stefanutti, Serafina, Di Giacomo, Claudia, Morozzi   +2 more
openaire   +1 more source

Treatment of Severe Hypercolesterolaemia by LDL-Apheresis

Biomaterials, Artificial Cells and Immobilization Biotechnology, 1991
The most severe forms of hypercholesterolaemia scarcely respond to diet and conventional drugs administration and need, therefore, alternative treatments. Terapeutic Plasma Exchange demonstrated an improved survival of subjects with Familial Hypercholesterolaemia (FH) in spite of its limitations.
SCARPATO, NICOLA, Gnasso A, Nappi G, Falco C, POSTIGLIONE, ALFREDO, Formisano S, Mancini M.   +6 more
openaire   +3 more sources

Long term effect of LDL apheresis in Japan. LDL Apheresis Study Group.

Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology, 1992
LDL-apheresis is introduced in many cases all over Japan. Among them, evaluation of long-term effect on ischemic heart disease (IHD) has made on 10 cases with homozygous familial hypercholesterolemia (FH) and 49 cases with heterozygous FH. As to homozygous FH, 3 patients had angina pectoris. Mean duration of treatment was 26 months (52 treatments). The
C, Naito, A, Yamamoto, Y, Saito, E, Muto, T, Nishide, M, Shinomiya, M, Mukai, S, Tomono, T, Sato, K, Yasuda   +9 more
openaire   +1 more source